Epona Biotech Limited – Trademark Portfolio
Entity Type: 99
Epona Biotech Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EPONA and STABLELAB. The owner is based in Sligo.
The Old Mill Building, Lyons Terrace
Sligo F91 X657 , IE
Showing of trademarks Trademarks
Trademark Classifications
Epona Biotech Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Epona Biotech Limited have?
Epona Biotech Limited has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Epona Biotech Limited file in?
Epona Biotech Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Epona Biotech Limited's most well-known trademarks?
Epona Biotech Limited's registered trademark portfolio includes well-known marks such as EPONA and STABLELAB. These are among 2 currently registered trademarks in the portfolio.
What is Epona Biotech Limited's trademark registration success rate?
Epona Biotech Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.